Serratus Anterior Block and Erector Spinae Block in Postoperative Analgesia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-01

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus anterior block and erector spinae block and control group. during anaesthesia:total intraoperative fentanyl required will be recorded. After surgery, all patients will be connected to PCA device containing morphine solution, the amount of morphine consumed during the first 24 hours will be recorded.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

US-Guided Serratus Anterior Plane Block Versus Thoracic Epidural in Patients Undergoing Thoracotomy

NCT05672394

Lung Cancer Acute Pain Chronic Pain

COMPLETED NA

Perioperative Thoracotomy Analgesia; Different Analgesic Modalities

NCT04264689

Analgesia

COMPLETED NA

Erector Spinae Block Versus PECS Block Type II for Breast Surgeries

NCT04284124

Analgesia

COMPLETED NA

Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries

NCT05429489

Analgesia

COMPLETED NA

Comparison of Erector Spinae Plane Block With Serratus Anterior Plane Block for Breast Surgery

NCT03579524

Postoperative Pain Breast Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

90 patients scheduled for thoracic cancer surgeries, allocated in 3 groups for serratus anterior block (SAB) and erector spinae block (ESB) and control group. During anaesthesia: total intraoperative fentanyl required will be recorded. After surgery, all patients will be connected to PCA device containing morphine solution, the amount of morphine consumed during the first 24 hours will be recorded. Other secondary outcomes are: numerical rating scales and postoperative pulmonary functions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

serratus anterior block

serratus anterior block with 20 ml bupivacaine

Group Type EXPERIMENTAL

Serratus anterior block (SAB)

Intervention Type PROCEDURE

Patients will receive a sonar guided serratus anterior plane block with 20 ml of bupivacaine 0.5%

Bupivacaine

Intervention Type DRUG

bupivacaine

erector spinae block

erector spinae block with 20 ml bupivacaine

Group Type EXPERIMENTAL

Erector spinae block

Intervention Type PROCEDURE

Patients will receive a sonar-guided erector spinae plane block with 20 ml of bupivacaine 0.5%

Bupivacaine

Intervention Type DRUG

bupivacaine

control group

sham block with 20 ml saline

Group Type SHAM_COMPARATOR

Saline (as a placebo)

Intervention Type DRUG

Patients will receive a sham block with 20 ml saline (as a placebo)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Serratus anterior block (SAB)

Patients will receive a sonar guided serratus anterior plane block with 20 ml of bupivacaine 0.5%

Intervention Type PROCEDURE

Erector spinae block

Patients will receive a sonar-guided erector spinae plane block with 20 ml of bupivacaine 0.5%

Intervention Type PROCEDURE

Saline (as a placebo)

Patients will receive a sham block with 20 ml saline (as a placebo)

Intervention Type DRUG

Bupivacaine

bupivacaine

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SAB group ESB group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with class II physical status (American Society of Anaesthesiologists) ,
* Age between 18-70 years,
* Scheduled for thoracic cancer surgery

Exclusion Criteria

* Patient refusal.
* Local infection at the site of the block.
* Cardiac dysfunction (ejection fraction \<45%).
* Significant respiratory disorders.
* Preexisting neurological or psychiatric disease.
* Allergy to one of the study drugs.
* Pregnancy.
* Coagulopathy

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No